Related Experiment Video
Updated: Mar 30, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Tricuspid and mitral endocarditis due to methicillin-resistant Staphylococcus aureus exhibiting vancomycin-creep
Pranathi Rao Sundaragiri1, Saraschandra Vallabhajosyula2, Toufik Mahfood Haddad3
1Division of Hospital Internal Medicine, Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
Abstract:
Right-sided infective endocarditis (RIE) is commonly due to Staphylococcus aureus and often involves the tricuspid valve (TV). A 31-year-old man with prior intravenous drug use presented with substernal pain, cough, dyspnoea and fever. Examination revealed a febrile, tachycardic male with peripheral infective endocarditis stigmata and right-heart failure. Laboratory parameters demonstrated leucocytosis, lactic acidosis and methicillin-resistant S. aureus (MRSA) bacteraemia. Echocardiography demonstrated multiple TV echodensities and chest imaging confirmed septic emboli. The MRSA species demonstrated 'vancomycin-creep', necessitating therapy with daptomycin and ceftaroline. Owing to persistent bacteraemia and septic shock, the patient underwent TV surgery, but continued to have a poor postoperative course with subsequent death. Indications for surgical therapy of RIE are limited to the European guidelines and most data are extrapolated from left-heart disease. MRSA exhibiting vancomycin-creep portends a poorer prognosis and requires aggressive therapy. We advocate the use of ceftaroline salvage therapy with daptomycin, pending further trials.
Insights
Right-sided infective endocarditis (RIE) caused by Staphylococcus aureus can be severe. Vancomycin-creep in MRSA indicates a poor prognosis, requiring aggressive treatment like daptomycin and ceftaroline.
Area of Science:
- Infectious Diseases
- Cardiology
- Critical Care Medicine
Background:
- Right-sided infective endocarditis (RIE) commonly involves Staphylococcus aureus and the tricuspid valve (TV).
- Intravenous drug use is a significant risk factor for RIE.
- Limited guidelines exist for surgical intervention in RIE, often extrapolated from left-sided disease.
Observation:
- A 31-year-old male with a history of intravenous drug use presented with symptoms of RIE, including fever, dyspnea, and right-heart failure.
- Laboratory findings revealed methicillin-resistant Staphylococcus aureus (MRSA) bacteremia with lactic acidosis.
- Echocardiography showed multiple vegetations on the tricuspid valve, and chest imaging confirmed septic emboli.
Findings:
- The MRSA isolate exhibited 'vancomycin-creep,' a phenomenon associated with reduced vancomycin susceptibility.
- Despite treatment with daptomycin and ceftaroline, the patient experienced persistent bacteremia and septic shock.
- Surgical intervention for the tricuspid valve did not improve the patient's outcome, leading to death.
Implications:
- Vancomycin-creep in MRSA-RIE portends a poorer prognosis and necessitates aggressive therapeutic strategies.
- Ceftaroline salvage therapy in combination with daptomycin may be a viable option for refractory MRSA-RIE.
- Further clinical trials are needed to establish optimal treatment guidelines for complex RIE cases, particularly those involving vancomycin-creep.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis III: Medical Management

